$WKC

WORLD KINECT CORP

0
1
0

No SEC Form 4 filings for $WKC in the last 30 days.

Med

3 Stocks With Recent Gains But Weak Fundamentals, According to May 2026 Analysis

An analysis from May 2026 identifies Health Catalyst (HCAT), Enphase Energy (ENPH), and World Kinect (WKC) as three stocks that have recently shown significant price gains but are underpinned by weak fundamental financial metrics. Health Catalyst struggles with plateaued billings and high marketing costs, Enphase Energy faces declining sales and free cash flow, and World Kinect operates with low gross margins and limited free cash flow. Despite their recent stock performance, the report suggests these companies may not be sustainable long-term investments due to underlying operational and financial challenges.

Michael Kasbar Sells 500 Shares of World Kinect (NYSE:WKC) Stock

Michael Kasbar, Chairman of World Kinect, sold 500 shares of WKC stock for a total of $13,750, reducing his position by 0.05%. Despite this insider selling and some analyst caution, the company recently reported a strong EPS and revenue beat, and Zacks upgraded the stock to "Strong Buy." Hedge funds have also increased their stakes, leading to mixed sentiment around the stock.

World Kinect Corp (WKC) reports insider sales totaling 44,500 shares

World Kinect Corp (WKC) filed a Rule 144 notice detailing proposed and recent sales of Common Stock, primarily consisting of vested restricted stock unit awards. The filing specifies a 500-share RSU vesting and multiple sales by Michael Kasbar, totaling 44,500 shares across several dates in March, April, and May 2026. These transactions resulted in significant proceeds, as outlined in the SEC document.